Lupin Healthcare (UK) has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) to market a generic version of Spiriva, the Mumbai-based drug firm said in a statement.
Lupin Healthcare (UK) has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) to market a generic version of Spiriva, the Mumbai-based drug firm said in a statement.
English 
हिन्दी